Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that a conference call for the Indian and overseas analysts is arranged by management to discuss the Company's unaudited financial results Quarter / Nine Months ended December 31, 2017, on Friday, February 09, 2018 at 2.30 pm local time. Dr Velumani A., Ph.D., CEO, A. Sundararaju, CFO, Sachin Salvi, GM-Finance and Vatsal Goyal- Head- Strategy and Corporate Development, will represent the Company.
The above information is a part of company’s filings submitted to BSE.
